Synthetic studies on himbacine,a potent antagonist of the muscarinic M2 subtype receptor. Part 2: synthesis and muscarinic M2 subtype antagonistic activity of the novel himbacine congeners modified at the C-3 position of lactone moiety |
| |
Authors: | Takadoi Masanori Yamaguchi Kentaro Terashima Shiro |
| |
Institution: | Discovery Research Laboratories, Kyorin Pharmaceutical Co. Ltd., 2399-1Nogi, Nogi-machi, Tochigi, 329-0114, Japan. masanori.takadoi@mb2.kyorin-pharm.co.jp |
| |
Abstract: | With an aim to disclose the convergency and flexibility of our previously explored synthetic route to natural himbacine 1, and moreover, to clarify some novel aspects of the structure-activity relationships of 1, we prepared various structural types of novel himbacine congeners, 3-demethylhimbacine (3-norhimbacine) 2 and 4-epi-3-demethylhimbacine (4-epi-3-norhimbacine) 4-epi-2 and their enantiomers (ent-2 and ent-4-epi-2), 11-methylhimbacine 3, and 3-epihimbacine 4 in optically pure forms by employing our methodology. All of the synthesized congeners correspond to the compounds modified at the C-3 position of gamma-lactone moiety involved in 1. Among these congeners, 3-demethylhimbacine (3-norhimbacine) 2 was found to exhibit more potent muscarinic M(2) receptor binding affinity than natural 1. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|